Literature DB >> 16897603

In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum.

F Campos1, R Durán, L Vidal, L R F Faro, M Alfonso.   

Abstract

Anatoxin-a (AnTx) is a natural neurotoxin, which acts as a potent and stereoselective agonist at the nicotinic acetylcholine receptors. The in vivo actions of the AnTx on dopamine (DA) release are scarcely characterized. The aim of this study was to determine the neurochemical bases for AnTx-induced striatal DA release, using the brain microdialysis technique, in freely moving rats. Local application of AnTx (3.5 mM) through the microdialysis probe produced an increase in striatal DA levels (701 +/- 51% with respect to basal values). The effect of infusion of AnTx in Ca(2+)-free Ringer medium, in Na(+)-free Ringer medium and with TTX in the medium, was inhibited. Also, reserpine pre-treatment blocked the action of AnTx on striatal DA levels. To investigate the involvement of the DA transporter, the effects of AnTx were observed in the presence of nomifensine. The coadministration of AnTx and nomifensine evoked an additive effect on striatal DA levels. The latter results show that the DA release is not mediated by a decreased DA uptake. Taken as a whole, these results suggest that the effects of AnTx are predominantly mediated by an exocytotic mechanism, Ca(2+)-, Na(+)- and TTX-dependent, and not by a mechanism mediated by the DA transporter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897603     DOI: 10.1007/s00702-006-0542-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  63 in total

1.  Analysis of high intracellular [Na+]-induced release of [3H]noradrenaline in rat hippocampal slices.

Authors:  Z Gerevich; L Tretter; V Adam-Vizi; M Baranyi; J P Kiss; T Zelles; E S Vizi
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 3.  Nicotinic receptors in the development and modulation of CNS synapses.

Authors:  L W Role; D K Berg
Journal:  Neuron       Date:  1996-06       Impact factor: 17.173

4.  Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons.

Authors:  S Koyama; N Matsumoto; C Kubo; N Akaike
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

5.  Anatoxin-a a potent ligand for nicotinic cholinergic receptors in rat brain.

Authors:  X Zhang; P Stjernlöf; A Adem; A Nordberg
Journal:  Eur J Pharmacol       Date:  1987-03-31       Impact factor: 4.432

6.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.

Authors:  R H Roth; L C Murrin; J R Walters
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

7.  Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum.

Authors:  D Marshall; L Soliakov; P Redfern; S Wonnacott
Journal:  Neuropharmacology       Date:  1996       Impact factor: 5.250

8.  Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study.

Authors:  M Alfonso; R Durán; F Campos; D Perez-Vences; L R F Faro; B Arias
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

9.  A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice.

Authors:  W J Wieczorek; Z L Kruk
Journal:  Brain Res       Date:  1994-09-19       Impact factor: 3.252

10.  Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.

Authors:  M J Heeringa; E D Abercrombie
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.